FDA approves new combination pill for HIV treatment for some patients – Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection, is approved in US by FDA.
New pathway to cheap insulin — Researchers from Helmholtz Centre in Braunschweig, Germany, publish new and more efficient method to manufacture insulin – More than eight million diabetics live in Germany. Diabetes is not restricted to our prosperous society and the highest growth rates often occur in countries with aspiring economies such as in Asia.
Obesity comes with plenty of health risks, but there’s one that’s perhaps not so well known: an increased risk of developing cancer, and especially certain types of cancer like liver cancer. – Epidemiological studies indicate that being overweight or obese is associated with increased cancer risk. The most dramatic effect of obesity on cancer risk has been noted for a common form of liver cancer called hepatocellular carcinoma or HCC.
Toward explaining why hepatitis B hits men harder than women – Researchers are trying to explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates — hitting men harder than women.
First three cases of likely HIV transmission to infants via pre-chewed food suggest cautioning HIV-positive caregivers against prechewing food. – Researchers have uncovered the first cases in which HIV almost certainly was transmitted from mothers or other caregivers to children through pre-chewed food.
AIDS Action Statement on HIV Vaccine Awareness Day: Reason to Hope. – Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.
HIV positive and HIV negative patients have similar survival rates following liver transplant. – HIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark.
The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral-naive and -experienced patients warrant an update of the International AIDS Society?USA guidelines for the use of antiretroviral therapy in adult human immunodeficiency virus (HIV) infection. – An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS.